Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: Comparing treatment with risperidone and haloperidol

References

• Addington D, Addington J, Atkinson M. 1996. A psychometric comparison of the Calgary Depression Scale for Schizophrenia and the Hamilton Depression Rating Scale. Schizophr Res 19:205–212.
   PubMed Web of Science ®Google Scholar
• Addington D, Addington J, Patten S. 1998. Depression in people with first-episode schizophrenia. Br J Psychiatry Suppl 172:90–92.
   Google Scholar
• American Psychiatric Association. 1987. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.
   Google Scholar
• American Psychiatric Association. 1994. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association.
   Google Scholar
• Andreasen NC, Carpenter WT Jr, Kane JM, Lasser RA, Marder SR, Weinberger DR. 2005. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry 162:441–449.
   PubMed Web of Science ®Google Scholar
• Bartels SJ, Drake RE. 1988. Depressive symptoms in schizophrenia: comprehensive differential diagnosis. Compr Psychiatry 29:467–483.
   PubMed Web of Science ®Google Scholar
• Baynes D, Mulholland C, Cooper SJ, Montgomery RC, MacFlynn G, Lynch G, . 2000. Depressive symptoms in stable chronic schizophrenia: prevalence and relationship to psychopathology and treatment. Schizophr Res 45:47–56.
   PubMed Web of Science ®Google Scholar
• Bermanzohn PC, Siris SG. 1992. Akinesia: a syndrome common to parkinsonism, retarded depression, and negative symptoms of schizophrenia. Compr Psychiatry 33:221–232.
   PubMed Web of Science ®Google Scholar
• Birchwood M, Mason R, MacMillan F, Healy J. 1993. Depression, demoralization and control over psychotic illness: a comparison of depressed and non-depressed patients with a chronic psychosis. Psychol Med 23:387–395.
   PubMed Web of Science ®Google Scholar
• Bottlender R, Strauss A, Moller HJ. 2000. Prevalence and background factors of depression in first admitted schizophrenic patients. Acta Psychiatr Scand 101:153–160.
   PubMed Web of Science ®Google Scholar
• Bressan RA, Costa DC, Jones HM, Ell PJ, Pilowsky LS. 2002. Typical antipsychotic drugs – D(2) receptor occupancy and depressive symptoms in schizophrenia. Schizophr Res 56:31–36.
   PubMed Web of Science ®Google Scholar
• Cohen LJ, Test MA, Brown RL. 1990. Suicide and schizophrenia: data from a prospective community treatment study. Am J Psychiatry 147:602–607.
   PubMed Web of Science ®Google Scholar
• Cording C. 1998. [Conceptual aspects in development and implementation of basic psychiatric documentation]. Psychiatr Prax 25:175–178.
   PubMedGoogle Scholar
• Corrigan PW. 2007. How clinical diagnosis might exacerbate the stigma of mental illness. Soc Work 52:31–39.
   PubMed Web of Science ®Google Scholar
• Drake RJ, Pickles A, Bentall RP, Kinderman P, Haddock G, Tarrier N, Lewis SW. 2004. The evolution of insight, paranoia and depression during early schizophrenia. Psychol Med 34:285–292.
   PubMed Web of Science ®Google Scholar
• Emsley R, Oosthuizen PP, Kidd M, Koen L, Niehaus DJ, Turner HJ. 2006. Remission in first-episode psychosis: predictor variables and symptom improvement patterns. J Clin Psychiatry 67: 1707–1712.
   PubMed Web of Science ®Google Scholar
• Fitzgerald PB, Rolfe TJ, Brewer K, Filia K, Collins J, Filia S, . 2002. Depressive, positive, negative and parkinsonian symptomsin schizophrenia. Aust NZ J Psychiatry 36:340–346.
   PubMed Web of Science ®Google Scholar
• Furtado VA, Srihari V, Kumar A. 2009. Atypical antipsychotics for people with both schizophrenia and depression. Schizophr Bull 35:297–298.
   Google Scholar
• Gaebel W, Riesbeck M, Wolwer W, Klimke A, Eickhoff M, Jockers-Scherubl MC, . 2007. Maintenance treatment with risperidone or low-dose haloperidol in first-episode schizophrenia: 1-year results of a randomized controlled trial within the German Research Network on Schizophrenia. J Clin Psychiatry 68:1763–1774.
   PubMedGoogle Scholar
• Guy W. 1976. Abnormal Involuntary Movement Scale (AIMS). ECDEU Assessment Manual for Psychopharmacology (revised ed.). Washington, DC: US Department of Health, Education and Welfare.
   Google Scholar
• Hamilton M. 1967. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol 6:278–296.
   PubMed Web of Science ®Google Scholar
• Harrington DP, Fleming TR. 1982. A class of rank test procedures for censored survival data. Biometrika 69:553–566.
   Web of Science ®Google Scholar
• Herz M. 1985. Prodromal symptoms and prevention of relapse in schizophrenia. J Clin Psychiatry 46:22–25.
   Google Scholar
• Hirsh S.R., Jolley A, Barnes T. 1990. Are depressive symptoms part of the schizophrenic syndrome? DeLisi LE. Depression in schizophrenia. Washington, DC: American Psychiatric Press. 27–37.
   Google Scholar
• Jager M, Riedel M, Schmauss M, Pfeiffer H, Laux G, Naber D, . 2008. Depression during an acute episode of schizophrenia or schizophreniform disorder and its impact on treatment response. Psychiatry Res 158:297–305.
   Google Scholar
• Johnson DA. 1981. Studies of depressive symptoms in schizophrenia. Br J Psychiatry 139:89–101.
   PubMed Web of Science ®Google Scholar
• Kay SR, Opler LA, Lindenmayer JP. 1988. Reliability and validity of the positive and negative syndrome scale for schizophrenics. Psychiatry Res 23:99–110.
   PubMed Web of Science ®Google Scholar
• Kilzieh N, Wood AE, Erdmann J, Raskind M, Tapp A. 2003. Depression in Kraepelinian schizophrenia. Compr Psychiatry 44:1–6.
   PubMed Web of Science ®Google Scholar
• Kinon BJ, Chen L, Ascher-Svanum H, Stauffer VL, Kollack-Walker S, Zhou W, . 2010. Early response to antipsychotic drug therapy as a clinical marker of subsequent response in the treatment of schizophrenia. Neuropsychopharmacology 35:581–590.
   PubMed Web of Science ®Google Scholar
• Koreen AR, Siris SG, Chakos M, Alvir J, Mayerhoff D, Lieberman J. 1993. Depression in first-episode schizophrenia. Am J Psychiatry 150:1643–1648.
   PubMed Web of Science ®Google Scholar
• Leucht S, Davis JM, Engel RR, Kane JM, Wagenpfeil S. 2007. Defining ‘response’ in antipsychotic drug trials: recommendations for the use of scale-derived cutoffs. Neuropsychopharmacology 32:1903–1910.
   PubMed Web of Science ®Google Scholar
• Lysaker PH, Tsai J, Yanos P, Roe D. 2008. Associations of multiple domains of self-esteem with four dimensions of stigma in schizophrenia. Schizophr Res 98:194–200.
   PubMed Web of Science ®Google Scholar
• Mauri MC, Moliterno D, Rossattini M, Colasanti A. 2008. Depression in schizophrenia: comparison of first- and second-generation antipsychotic drugs. Schizophr Res 99:7–12.
   PubMedGoogle Scholar
• McGlashan TH, Carpenter WT Jr. 1976. Postpsychotic depression in schizophrenia. Arch Gen Psychiatry 33:231–239.
   PubMed Web of Science ®Google Scholar
• Moller H.-J. 2008. Drug treatment of depressive symptoms in schizophrenia. Clin Schizophr Rel Psychoses 1:328–340.
   Google Scholar
• Moller HJ, Riedel M, Jager M, Wickelmaier F, Maier W, Kuhn KU, . 2008. Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia. Int J Neuropsychopharmacol 11:985–997.
   PubMed Web of Science ®Google Scholar
• Oosthuizen P, Emsley RA, Roberts MC, Turner J, Keyter L, Keyter N, Torreman M. 2002. Depressive symptoms at baseline predict fewer negative symptoms at follow-up in patients with first-episode schizophrenia. Schizophr Res 58:247–252.
   PubMed Web of Science ®Google Scholar
• Perkins DO, Gu H, Weiden PJ, McEvoy JP, Hamer RM, Lieberman JA. 2008. Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. J Clin Psychiatry 69:106–113.
   PubMed Web of Science ®Google Scholar
• Peuskens J, Moller HJ, Puech A. 2002. Amisulpride improves depressive symptoms in acute exacerbations of schizophrenia: comparison with haloperidol and risperidone. Eur Neuropsychopharmacol 12:305–310.
   PubMed Web of Science ®Google Scholar
• R Development Core Team. A language and environment for statistical computing. http://www.R-project.org. 2008. Vienna, Austria: Foundation for Statistical Computing. Ref Type: Computer Program.
   Google Scholar
• Resnick SG, Rosenheck RA, Lehman AF. 2004. An exploratory analysis of correlates of recovery. Psychiatr Serv 55:540–547.
   PubMed Web of Science ®Google Scholar
• Siris SG. 2000. Depression in schizophrenia: perspective in the era of “Atypical” antipsychotic agents. Am J Psychiatry 157: 1379–1389.
   PubMed Web of Science ®Google Scholar
• Tapp A, Kilzieh N, Wood AE, Raskind M, Tandon R. 2001. Depression in patients with schizophrenia during an acute psychotic episode. Compr Psychiatry 42:314–318.
   PubMed Web of Science ®Google Scholar
• Tollefson GD, Andersen SW. 1999. Should we consider mood disturbance in schizophrenia as an important determinant of quality of life? J Clin Psychiatry 60(Suppl 5):23–29; discussion 30:23–29.
   Google Scholar
• Zisook S, McAdams LA, Kuck J, Harris MJ, Bailey A, Patterson TL, . 1999. Depressive symptoms in schizophrenia. Am J Psychiatry 156:1736–1743.
   PubMed Web of Science ®Google Scholar